FDA authorizes 4 flavored nicotine pouches
The Food and Drug Administration (FDA) on Tuesday granted marketing authorization to four new flavored nicotine pouches as part of the agency's tobacco review pilot program launched last year. Four nicotine pouch products — Rich Berry 2 mg, Cappuccino 2 mg, Cappuccino 4 mg and Autumn Spice 2 mg — from Helix Innovations LLC received...
The U.S. Food and Drug Administration recently approved marketing for four new flavored nicotine pouch products, increasing the total number of such products authorized by the FDA to 30. These pouches, manufactured by subsidiaries of two of the world's largest tobacco companies, Philip Morris International and Altria Group, have raised concerns among health advocates due to their potential appeal to young users.
The FDA's approval comes as part of a series of steps aimed at boosting the fast-growing nicotine pouch sector, with sales of these products surging by 250% between January 2023 and August 2025. While the FDA claims that the modified risk authorization for ZYN, one of the brands covered, does not imply safety, critics warn that the products pose a risk for nicotine addiction among youth.
Written by urgent.news from CBS News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
